Titlebook: ;

只看該作者 · 發(fā)表于 2025-3-23 19:08:51

Group-Sequential Clinical Trials with Multiple Co-Objectives

只看該作者 · 發(fā)表于 2025-3-23 23:12:18

只看該作者 · 發(fā)表于 2025-3-24 02:44:49

只看該作者 · 發(fā)表于 2025-3-24 10:00:36

只看該作者 · 發(fā)表于 2025-3-24 11:21:45

只看該作者 · 發(fā)表于 2025-3-24 14:58:27

Controversies and Future Challenges,her design features. This includes clinical trials with more than two interventions (e.g., dose-selection clinical trials): trials with time-to-event endpoints and trials with targeted subgroups and enrichment clinical trial designs. In Chap. ., we briefly discuss the issues in the design of these trials.

只看該作者 · 發(fā)表于 2025-3-24 19:15:24

只看該作者 · 發(fā)表于 2025-3-24 23:16:05

Future Developments,her design features. This includes clinical trials with more than two interventions (e.g., dose-selection clinical trials): trials with time-to-event endpoints and trials with targeted subgroups and enrichment clinical trial designs. In Chap. ., we briefly discuss the issues in the design of these trials.

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 21:47
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved